Skip to main content

Table 2 Stool microbiology and parasitology at admission

From: Lactobacillus caseistrain GG in the treatment of infants with acute watery diarrhea: A randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]

 

Placebo group

N

LGG group

N

P

Rotavirus

33 (39.3%)

84

22 (24.4%)

90

0.052

EPEC

12 (17.6%)

68

9 (13.2%)

68

0.635

Vibrio cholerae

7 (8.0%)

88

11 (12.4%)

89

0.471

Campylobacter sp.

6 (6.8%)

88

9 (10.1%)

89

0.605

Shigella sp.

9 (10.2%)

88

4 (4.5%)

89

0.241

Aeromonas sp.

2 (2.3%)

88

1 (1.1%)

89

0.992

Salmonella sp.

0 (0.0%)

88

1 (1.1%)

89

0.995

Negative microbiology

25 (36.8%)

68

32 (47.1%)

68

0.452

Cryptosporidium parvum

6 (7.0%)

86

2 (2.2%)

89

0.256

Giardia lambliae

2 (2.3%)

86

3 (3.4%)

89

0.969

Strongyloides stercolaris

1 (1.2%)

86

0 (0.0%)

89

0.986

Trichomonas sp.

0 (0.0%)

86

2 (2.2%)

89

0.492

Negative parasitology

77 (89.5%)

86

82 (92.1%)

89

0.738

Negative microbiology and parasitology

22 (35.5%)

62

30 (44.8%)

67

0.371

  1. No patients were found positive for the following parasites: Ascaris, Enterobius, Trichuris, E. hystolytica, Ancylostoma, Necator.
  2. ETEC identification was not done
  3. Values are n (%)